US president Donald Trump could play an unlikely role in deciding the fate of one of SQN Asset Finance Income's problem investments.
Former investment industry boss Daniel Godfrey reveals Labour leader Jeremy Corbyn and, indirectly, the Prince of Wales inspired forthcoming launch of his long-term, multi-manager fund.
It’s almost official: British Empire is not going to be the next Alliance Trust. But is it a good investment?
Woodford Patient Capital has evolved into a more focused portfolio, with performance ticking up this year after a disappointing 2016.
Biotechnology stocks have come under political pressure in the US, but history suggests they will recover strongly, says Biotech Growth manager Sven Borho.
Investment and property veteran targets warehouse sector to expand scope of high-yielding Pacific Industrial & Logistics Reit he launched last year.
Popular alternative income fund HICL Infrastructure leads consortium to buy High Speed 1 rail project, a move that gains it more inflation-linked revenue but could put more pressure on its share price.
Rising interest rates and gilt yields are weakening shares in many alternative income funds, including UK’s biggest listed social infrastructure company.
Finsbury Growth & Income Trust star manager explains why Hargreaves Lansdown, Rathbones and Schroders remain among his favourite growth stocks despite regulatory pressure on fees.
Investment trust gives fund manager Philip Matthews more freedom to invest in smaller companies as it seeks to revive performance.